Can anyone explain the thought process behind

anonymous

Guest
Duane’s comment on yesterdays call of EXPANDING the ISS team ? I feel like they have literally nothing to do with the current drug portfolio so why would the company need more of them….
 








I think he meant an expansion in responsibilities, as in taking over some of the stuff the ADSOCS were doing in the hospitals to open access pipelines. It makes sense.
 












ISS better be prepared to find out their top accounts will be handled by someone else. The expansion that they speak of will actually eliminate at least 2 CVA ISS’s but the rest will join the new sales force alignment and they consider that an expansion.
 








ISS better be prepared to find out their top accounts will be handled by someone else. The expansion that they speak of will actually eliminate at least 2 CVA ISS’s but the rest will join the new sales force alignment and they consider that an expansion.

Actually not true. Go recheck your source.